Mu-Peng Li

476 total citations
27 papers, 332 citations indexed

About

Mu-Peng Li is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Hematology. According to data from OpenAlex, Mu-Peng Li has authored 27 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Hematology. Recurrent topics in Mu-Peng Li's work include Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Diabetes Treatment and Management (7 papers) and Platelet Disorders and Treatments (5 papers). Mu-Peng Li is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Diabetes Treatment and Management (7 papers) and Platelet Disorders and Treatments (5 papers). Mu-Peng Li collaborates with scholars based in China, United Kingdom and United States. Mu-Peng Li's co-authors include Xiaoping Chen, Jie Tang, Yanjiao Zhang, Wenjing Zeng, Linyu Yu, Congmin Zhang, Jie Tang, Yan Han, Xiao‐Ping Chen and Xiaolei Hu and has published in prestigious journals such as Gene, International Journal of Environmental Research and Public Health and International Journal of Biological Macromolecules.

In The Last Decade

Mu-Peng Li

24 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mu-Peng Li China 11 112 92 74 47 45 27 332
Xiling Jiang United States 10 114 1.0× 98 1.1× 124 1.7× 62 1.3× 90 2.0× 18 455
Kavita Shalia India 10 127 1.1× 57 0.6× 31 0.4× 74 1.6× 30 0.7× 32 334
Lin Liao China 11 58 0.5× 80 0.9× 46 0.6× 57 1.2× 68 1.5× 22 313
Jingjing Jiang China 10 183 1.6× 140 1.5× 67 0.9× 29 0.6× 42 0.9× 21 447
Guangyan Mu China 11 143 1.3× 75 0.8× 47 0.6× 99 2.1× 20 0.4× 52 383
Joke Breyne Belgium 10 164 1.5× 97 1.1× 62 0.8× 90 1.9× 19 0.4× 18 444
Monika Philipp Germany 11 144 1.3× 127 1.4× 86 1.2× 72 1.5× 100 2.2× 14 577
Solenn Le-Guennec France 8 84 0.8× 115 1.3× 116 1.6× 24 0.5× 14 0.3× 10 294
Xu Ping Wang China 8 129 1.2× 92 1.0× 22 0.3× 53 1.1× 85 1.9× 10 341

Countries citing papers authored by Mu-Peng Li

Since Specialization
Citations

This map shows the geographic impact of Mu-Peng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu-Peng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu-Peng Li more than expected).

Fields of papers citing papers by Mu-Peng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mu-Peng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu-Peng Li. The network helps show where Mu-Peng Li may publish in the future.

Co-authorship network of co-authors of Mu-Peng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mu-Peng Li. A scholar is included among the top collaborators of Mu-Peng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mu-Peng Li. Mu-Peng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiale, Zicheng Zhang, Qing Huang, et al.. (2025). Firmicutes in gut microbiota: hormonal influence on breast cancer in obese individuals. Discover Oncology. 16(1). 1750–1750.
2.
Zhang, Zicheng, Qing Huang, Zhi‐Qiang Ling, et al.. (2025). Cuproptosis- and m6A-related lncRNA prognostic signature for breast cancer, in which Z68871.1 contributes to triple-negative breast cancer progression. International Journal of Biological Macromolecules. 321(Pt 2). 146321–146321. 1 indexed citations
3.
Li, Mu-Peng, Fangfang Liu, Peiwen Zhang, et al.. (2024). Pharmacokinetics and Safety of Estradiol Valerate Tablet and Its Generic: A Phase 1 Bioequivalence Study in Healthy Chinese Postmenopausal Female Subjects. Drug Design Development and Therapy. Volume 18. 2891–2904. 2 indexed citations
4.
Hu, Xiaolei, Mu-Peng Li, He Li, et al.. (2023). Decreased platelet miR-199a-5p level might lead to high on-clopidogrel platelet reactivity in patients with coronary artery disease. Platelets. 34(1). 2200860–2200860. 3 indexed citations
5.
Li, Mu-Peng, et al.. (2023). CD80 DNA methylation and single-nucleotide polymorphism associated with clopidogrel response: a whole-genome DNA methylation analysis in acute coronary syndrome. Research and Practice in Thrombosis and Haemostasis. 7(2). 100093–100093.
6.
Mai, Gang, et al.. (2021). A Randomized Phase 1 Pharmacokinetic Study Comparing the Potential Biosimilar LRG201902 With Liraglutide (Victoza®) in Healthy Male Subjects. Frontiers in Pharmacology. 11. 610880–610880. 5 indexed citations
7.
Li, Mu-Peng, et al.. (2020). Association of FMO3 rs1736557 polymorphism with clopidogrel response in Chinese patients with coronary artery disease. European Journal of Clinical Pharmacology. 77(3). 359–368. 7 indexed citations
8.
Zhang, Yanjiao, He Li, Xiaolei Hu, et al.. (2018). CRISPLD1 rs12115090 polymorphisms alters antiplatelet potency of clopidogrel in coronary artery disease patients in Chinese Han. Gene. 678. 226–232. 12 indexed citations
9.
Li, He, Yanjiao Zhang, Mu-Peng Li, et al.. (2018). Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease. Frontiers in Pharmacology. 9. 1039–1039. 10 indexed citations
10.
Hu, Xiaolei, et al.. (2017). AGXT2: An unnegligible aminotransferase in cardiovascular and urinary systems. Journal of Molecular and Cellular Cardiology. 113. 33–38. 12 indexed citations
11.
Hu, Xiaolei, Wenjing Zeng, Mu-Peng Li, et al.. (2017). AGXT2 rs37369 polymorphism predicts the renal function in patients with chronic heart failure. Gene. 637. 145–151. 6 indexed citations
12.
Yang, Yonglong, Yanjiao Zhang, Wei Liu, et al.. (2017). High Expression of AHSP, EPB42, GYPC and HEMGN Predicts Favorable Prognosis in FLT3-ITD-Negative Acute Myeloid Leukemia. Cellular Physiology and Biochemistry. 42(5). 1973–1984. 19 indexed citations
13.
Li, Mu-Peng, Yaodong Hu, Zhipeng Wen, et al.. (2016). Association of PEAR1 rs12041331 polymorphism and pharmacodynamics of ticagrelor in healthy Chinese volunteers. Xenobiotica. 47(12). 1130–1138. 20 indexed citations
14.
Li, Mu-Peng, Yaodong Hu, Xiaolei Hu, et al.. (2016). MiRNAs and miRNA Polymorphisms Modify Drug Response. International Journal of Environmental Research and Public Health. 13(11). 1096–1096. 27 indexed citations
15.
Li, Mu-Peng, Yaodong Hu, Huilan Li, et al.. (2016). No Effect of <i>SLCO1B1</i> and <i>CYP3A4/5</i> Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Male Subjects. Biological and Pharmaceutical Bulletin. 40(1). 88–96. 13 indexed citations
16.
Li, Mu-Peng, Jie Tang, Zhipeng Wen, et al.. (2015). Influence of P2Y12 polymorphisms on platelet activity but not ex-vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects. Blood Coagulation & Fibrinolysis. 26(8). 874–881. 12 indexed citations
17.
Li, Mu-Peng, Yan Xiong, Chunxue Wang, et al.. (2014). Association of platelet ITGA2B and ITGB3 polymorphisms with ex vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects. International Journal of Hematology. 99(3). 263–271. 13 indexed citations
18.
Tang, Jie, Mu-Peng Li, Hong‐Hao Zhou, & Xiaoping Chen. (2014). Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists. Current Vascular Pharmacology. 13(5). 566–577. 8 indexed citations
19.
Sun, Tao, Ji‐Peng Zhou, Mu-Peng Li, et al.. (2013). Correlations of DDAH1 Transcript Variants with Human Endothelial Asymmetric Dimethylarginine Metabolizing Activity. American Journal of Hypertension. 26(12). 1437–1444. 5 indexed citations
20.
Li, Mu-Peng, et al.. (2013). [SNPs discovery and linkage disequilibrium analysis of BSG in Chinese Han population].. PubMed. 38(12). 1208–16. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiling Jiang Breakdown of academic impact, for papers by Kavita Shalia Breakdown of academic impact, for papers by Lin Liao Breakdown of academic impact, for papers by Jingjing Jiang Breakdown of academic impact, for papers by Guangyan Mu Breakdown of academic impact, for papers by Joke Breyne Breakdown of academic impact, for papers by Monika Philipp Breakdown of academic impact, for papers by Solenn Le-Guennec Breakdown of academic impact, for papers by Xu Ping Wang
Rankless by CCL
2026